California Public Employees Retirement System’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-236,456
Closed -$6.63M 1226
2021
Q4
$6.63M Buy
236,456
+17,187
+8% +$527K ﹤0.01% 1124
2021
Q3
$7.45M Buy
219,269
+4,875
+2% +$176K 0.01% 1119
2021
Q2
$8.76M Buy
214,394
+44,767
+26% +$1.74M 0.01% 1093
2021
Q1
$6.83M Sell
169,627
-19,708
-10% -$1.07M 0.01% 1260
2020
Q4
$11.2M Buy
189,335
+30,135
+19% +$1.55M 0.01% 953
2020
Q3
$7.74M Buy
159,200
+14,400
+10% +$605K 0.01% 983
2020
Q2
$7M Buy
144,800
+112,700
+351% +$4.11M 0.01% 1009
2020
Q1
$892K Buy
32,100
+3,300
+11% +$92K ﹤0.01% 2084
2019
Q4
$862K Buy
+28,800
New +$827K ﹤0.01% 2456

Other funds holding ADPT

California Public Employees Retirement System's ADPT Position: Q1 2022 in Review

California Public Employees Retirement System sold out of Adaptive Biotechnologies (ADPT) in Q1 2022, closing a stake of 236,456 shares — an estimated $6.63M sold.

California Public Employees Retirement System first reported a position in ADPT in Q4 2019 and held it in 9 quarters. The position peaked at $11.2M in Q4 2020. 221 funds tracked by Wall St. Rank hold ADPT as of Q1 2022.

  • California Public Employees Retirement System reported no remaining Adaptive Biotechnologies position as of Q1 2022 after selling out during the quarter.
  • California Public Employees Retirement System sold 236,456 Adaptive Biotechnologies shares in Q1 2022, an estimated $6.63M.
  • California Public Employees Retirement System first reported a position in Adaptive Biotechnologies in Q4 2019 and held it in 9 quarters.
  • California Public Employees Retirement System's Adaptive Biotechnologies position peaked at $11.2M in Q4 2020.
  • 221 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2022.

Based on California Public Employees Retirement System's 13F filing for Q1 2022, filed 4 May 2022.